Bringing Value-Based Care into Oncology Landscape

Brillstein Collaborative Consulting CEO Lili Brillstein in a recent interview with AJMC discusses the challenges of bringing value-based care in the oncology landscape.

“New technology, quick approvals of new drugs, certainly make oncology a more challenging set of diagnoses to model than some others,” she said. “But again, being able to design a model around oncology, or really any other chronic disease, requires the same sorts of things that are required in any models.”

To watch the brief interview on AJMC’s website, click here.